发明名称 |
NEUROTROPHIC FACTOR MANF AND USES THEREOF |
摘要 |
The present invention generally relates to the field of treatment of neuronal disorders and more particularly to neurotrophic factor MANF and uses thereof. The present invention provides a pharmaceutical compound comprising MANF nucleic acid molecule, MANF protein or a functional fragment thereof for the treatment of a peripherial neuropathy including Alzheimer's disease, Parkinson's disease, epilepsy, drug addiction and ischemic brain injury. |
申请公布号 |
US2015020222(A1) |
申请公布日期 |
2015.01.15 |
申请号 |
US201414480975 |
申请日期 |
2014.09.09 |
申请人 |
HERANTIS PHARMA, PLC. |
发明人 |
SAARMA Mart;LINDHOLM Päivi;VOUTILAINEN Merja;PERÄNEN Johan;TUOMINEN Raimo;AIRAVAARA Mikko;LEPPÄNEN Veli-Matti;LINDAHL Maria;ANDRESSOO Jaan-Olle |
分类号 |
A61K38/18;A01K67/027;C07K14/475 |
主分类号 |
A61K38/18 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treatment of an individual having Alzheimer's disease, Parkinson's disease, epilepsy, drug addiction or ischemic brain injury, said method comprising:
administering to the individual a therapeutically effective amount of MANF polypeptide comprising the amino acid sequence of SEQ ID NO:2 or a functional fragment thereof, wherein said polypeptide is a mesencephalic astrocyte-derived neurotrophic factor (MANF) polypeptide, and wherein said functional fragment is a MANF polypeptide having SEQ ID NO:4 and is capable of preventing the 6-hydroxydopamine (6-OHDA)-induced degeneration of dopaminergic neurons. |
地址 |
Helsinki FI |